Source: PharmAust
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • PharmAust (PAA) receives a $708,000 research and development tax incentive refund
  • The company says the Australian Taxation Office (ATO) has recognised the research and development innovation of the clinical-stage biotechnology company’s wholly-owned subsidiaries, Epichem and Pitney Pharmaceuticals
  • The R&D incentive scheme is a program jointly administered by the ATO and AusIndustry, under which companies can receive up to a 43.5 per cent refundable tax offset of eligible expenses on research activities
  • PAA shares up 1.1 per cent to 9.2 cents

PharmAust (PAA) has received a $708,000 research and development tax incentive refund.

The company said the Australian Taxation Office (ATO) recognised the research and development innovation of the clinical-stage biotechnology company’s wholly owned subsidiaries, Epichem and Pitney Pharmaceuticals.

Following approval from the ATO, just over $708,000 was deemed refundable on PharmAust’s 2021 tax return and paid to the company.

The research and development incentive scheme is a program jointly administered by the ATO and AusIndustry, under which companies can receive up to a 43.5 per cent refundable tax offset on eligible expenses on research and development activities.

“We appreciate the continued support and acknowledgement by the Australian Government for the critical work undertaken in our R&D programs,” PharmAust Finance Director Sam Wright said.

“The receipt of the R&D refund strengthens PharmAust’s financial position to execute on our upcoming clinical trials.”

PAA shares were up 1.1 per cent to 9.2 cents at 10:33 am AEST.

PAA by the numbers
More From The Market Online
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…